LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83 rd American Academy of ...

A phase 3 trial confirms delgocitinib cream is safe and effective for long-term treatment of chronic hand eczema, maintaining disease control for up to 52 weeks.

Researchers have found in DELTA China trial that delgocitinib cream (Anzupgo) 20 mg/g significantly reduces severity of ...

Half of patients who used delgocitinib cream for chronic hand eczema had a profound response, and a third who stopped ...

The follow formulas feature everything from enriching vitamin A to soothing aloe vera, protective oatmeal and more nourishing ...

I didn’t really get into hand cream until 2020, when I’d started washing my hands with impressive frequency. It wasn’t too long before I realized my body lotion wasn’t going to cut it ...

for the potential treatment of adults with moderate to severe chronic hand eczema. Results from the phase 3 DELTA 2 study showed that delgocitinib cream met its primary endpoint of statistically ...

Hand eczema is a chronic inflammatory condition that causes dry, red, itchy skin on the hands and fingers. It can be caused by chemical or environmental irritants, allergy-causing substances ...

1 The findings from the post hoc analysis highlight that delgocitinib cream produced a strong treatment response across this subgroup of patients. A deep response, defined as a Hand Eczema Symptom ...

Lead Study Author, Year No. of Patients with Population Characteristics Ages (yr) AD Diagnostic Criteria Hand Eczema Pattern Cronin, 1985 263 with HE only and history of AD Not specified Patient ...